BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raj S, Kesari KK, Kumar A, Rathi B, Sharma A, Gupta PK, Jha SK, Jha NK, Slama P, Roychoudhury S, Kumar D. Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer. Mol Cancer 2022;21. [DOI: 10.1186/s12943-022-01503-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Q, Tie Y, Alu A, Ma X, Shi H. Targeted therapy for head and neck cancer: signaling pathways and clinical studies. Signal Transduct Target Ther 2023;8:31. [PMID: 36646686 DOI: 10.1038/s41392-022-01297-0] [Reference Citation Analysis]
2 Liu D, Zhou LQ, Cheng Q, Wang J, Kong WJ, Zhang SL. Developing a pyroptosis-related gene signature to better predict the prognosis and immune status of patients with head and neck squamous cell carcinoma. Front Genet 2022;13:988606. [PMID: 36685979 DOI: 10.3389/fgene.2022.988606] [Reference Citation Analysis]
3 Ming T, Tao Q, Tang S, Zhao H, Yang H, Liu M, Ren S, Xu H. Curcumin: An epigenetic regulator and its application in cancer. Biomedicine & Pharmacotherapy 2022;156:113956. [DOI: 10.1016/j.biopha.2022.113956] [Reference Citation Analysis]
4 Zheng W, Qian C, Tang Y, Yang C, Zhou Y, Shen P, Chen W, Yu S, Wei Z, Wang A, Lu Y, Zhao Y. Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1035323] [Reference Citation Analysis]
5 Wei Y, Li Y, Chen Y, Liu P, Huang S, Zhang Y, Sun Y, Wu Z, Hu M, Wu Q, Wu H, Liu F, She T, Ning Z. ALDH1: A potential therapeutic target for cancer stem cells in solid tumors. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1026278] [Reference Citation Analysis]
6 Centuori SM, Bauman JE. c-Met Signaling as a Therapeutic Target in Head and Neck Cancer. Cancer J 2022;28:346-53. [PMID: 36165722 DOI: 10.1097/PPO.0000000000000619] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Chi H, Jiang P, Xu K, Zhao Y, Song B, Peng G, He B, Liu X, Xia Z, Tian G. A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration. Front Genet 2022;13:984273. [DOI: 10.3389/fgene.2022.984273] [Reference Citation Analysis]
8 Xie Y. The role of mesenchymal-epithelial transition factor (c-MET) in cancer development and treatments. HSET 2022;6:255-268. [DOI: 10.54097/hset.v6i.969] [Reference Citation Analysis]
9 Yu ZL, Liu JY, Chen G. Small extracellular vesicle PD-L1 in cancer: the knowns and unknowns. NPJ Precis Oncol 2022;6:42. [PMID: 35729210 DOI: 10.1038/s41698-022-00287-3] [Reference Citation Analysis]
10 Pronina IV, Uroshlev LA, Moskovtsev AA, Zaichenko DM, Filippova EA, Fridman MV, Burdennyy AM, Loginov VI, Kazubskaya TP, Kushlinskii NE, Dmitriev AA, Braga EA, Brovkina OI. Dysregulation of lncRNA–miRNA–mRNA Interactome as a Marker of Metastatic Process in Ovarian Cancer. Biomedicines 2022;10:824. [DOI: 10.3390/biomedicines10040824] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Sharma A, Sinha S, Shrivastava N. Therapeutic Targeting Hypoxia-Inducible Factor (HIF-1) in Cancer: Cutting Gordian Knot of Cancer Cell Metabolism. Front Genet 2022;13:849040. [DOI: 10.3389/fgene.2022.849040] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]